Expertise in
7
conditions

Marcel Reiser

Richard Wagner Str. 13-17, 
Koeln, NW, DE 
Expertise in
7
conditions
Richard Wagner Str. 13-17, 
Koeln, NW, DE 

Overview

Marcel Reiser practices practicing medicine in Koeln, Germany.

Mr. Reiser is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Secondary Immunodeficiency (SID), Adult Immune Thrombocytopenia, Sudden Infant Death Syndrome (SIDS), Atherectomy, and Angioplasty.

He is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Richard Wagner Str. 13-17, Koeln, NW 50674, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Enrollment Status: Terminated
Publish Date: May 16, 2025
Intervention Type: Drug
Study Drug: Aspirin
Study Phase: Phase 3
Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy Alone
Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy Alone
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug, Radiation
Study Drugs: Gemcitabine, FOLFIRINOX
Study Phase: Phase 3
View 1 Less Clinical Trial

43 Total Publications

Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy - An Exploratory Analysis of the INFINITY Precision Oncology Registry.
Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy - An Exploratory Analysis of the INFINITY Precision Oncology Registry.
Journal: OncoTargets and therapy
Published: April 01, 2026

Frequently Asked Questions about Marcel Reiser

Is Marcel Reiser a top-rated expert for Secondary Immunodeficiency (SID)?

MediFind is an objective health platform that identifies experts based on real-world data. Marcel Reiser is classified as an Advanced expert for Secondary Immunodeficiency (SID), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marcel Reiser participate in research or clinical trials?

Yes. Marcel Reiser has published 43 articles and abstracts on conditions like Secondary Immunodeficiency (SID). You can view a list of Marcel Reiser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Reiser's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile